Improving cancer clinical trial enrollment and diversity
Official title: 2024 SBIR TOPIC 465: CANCER PREVENTION AND TREATMENT CLINICAL TRIALS TOOLS FOR RECRUITMENT AND RETENTION OF DIVERSE POPULATIONS
Funded at Mednet, INC. · NIH-11199161 · Data updated 2026-11-12
This study is working to help more people from different backgrounds join cancer clinical trials by using a special online tool that gives doctors personalized suggestions about available trials, making it easier for them to connect eligible patients with these important research opportunities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mednet, INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 16, 2024 |
| Project end | September 15, 2026 |
| Funding year | 2024 |
| Award (this year) | $2,000,000 |
| NIH project number | 75N91024C00071-0-9999-1 |
| Project ID | NIH-11199161 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are cancer patients from diverse backgrounds who are eligible for clinical trials.
✕Less likely to help
Patients who are not diagnosed with cancer or those who do not meet the eligibility criteria for clinical trials may not benefit from this research.
What this research studies
This research focuses on enhancing the enrollment of diverse populations in cancer clinical trials by utilizing an interactive platform called theMednet. It aims to improve oncologists' awareness of available clinical trials through tailored recommendations based on their activity and patient history. By targeting messaging to physicians at the point of care, the project seeks to encourage them to enroll eligible patients. Additionally, it will develop predictive tools to reach underrepresented populations in clinical trials, ultimately aiming to increase diversity in cancer research participation.
Why it matters
Potential benefit: If successful, this research could lead to more inclusive cancer clinical trials, improving treatment options and outcomes for diverse patient populations.
How similar studies have gone: Previous research has shown success in improving clinical trial enrollment through targeted physician engagement strategies, making this approach promising yet innovative.
Where this research is happening
-
Mednet, INC.
New York, United States Active
Researchers
- Principal investigator: Housri, Nadine — Mednet, INC.
- Study coordinator: Housri, Nadine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.